CI_ChemClass CI_with has_DoseForm has_Ingredient has_MoA has_PE may_treat drug associated with AE Adrenergic alpha-Antagonists [MoA] Drug Hypersensitivity [Disease/Finding] Hypertension [Disease/Finding] Hypotension [Disease/Finding] Prostatic Hyperplasia [Disease/Finding] Urinary Retention [Disease/Finding] Quinazolines [Chemical/Ingredient] Arterial Vasodilation [PE] Decreased Bladder Sphincter Tone [PE] Venous Vasodilation [PE] [CV150] ALPHA BLOCKERS/RELATED Oral Tablet [Dose Form] TERAZOSIN HYDROCHLORIDE TERAZOSIN HCL 1MG TAB [VA Product] 1 C0980495 TERAZOSIN HCL 1MG TAB 313216 盐酸特拉唑嗪片 TERAZOSIN TAB <Product_Component>TERAZOSIN HYDROCHLORIDE</Product_Component><Strength>1</Strength><Unit>MG</Unit><VA.IEN>2048</VA.IEN> C51690 N0000165732 4008759 Terazosin 1 MG Oral Tablet TERAZOSIN HCL 1MG TAB <VANDF_Record>50.68^8290^Inactive/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>8290</VA_IEN><VA_Status>Inactive/Master</VA_Status> VA Product 0 MG Decreased Blood Pressure [PE] Terazosin [Chemical/Ingredient] headache AE asthenia AE dizziness AE palpitation AE nausea AE orthostatic hypotension AE TERAZOSIN HCL 1MG TAB [VA Product] N0000165732 C51690 1 4008759 C0980495 Terazosin 1 MG Oral Tablet TERAZOSIN HCL 1MG TAB <VANDF_Record>50.68^8290^Inactive/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>8290</VA_IEN><VA_Status>Inactive/Master</VA_Status> TERAZOSIN HCL 1MG TAB VA Product 313216 0 盐酸特拉唑嗪片 TERAZOSIN TAB MG <Product_Component>TERAZOSIN HYDROCHLORIDE</Product_Component><Strength>1</Strength><Unit>MG</Unit><VA.IEN>2048</VA.IEN>